Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steroid hypothermia.

W Gill, S Wilson, W B Long

    Surgery, Gynecology & Obstetrics
    |June 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    High-dose Solu-Medrol (methylprednisolone sodium succinate) effectively reduced fever in most septic shock patients. This treatment improved patient condition, with effects lasting around 30 hours.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A G protein-coupled receptor for UDP-glucose.

    The Journal of biological chemistry·2001
    Same author

    The concentration of AS-1 RBCs after inverted gravity sedimentation for neonatal transfusions.

    Transfusion·2000
    Same author

    Vibrio parahaemolyticus infections in the United States, 1973-1998.

    The Journal of infectious diseases·2000
    Same author

    Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.

    Brain research. Molecular brain research·2000
    Same author

    Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3.

    The Journal of biological chemistry·2000
    Same author

    Initial management strategies for dyspepsia.

    The Cochrane database of systematic reviews·2000
    Same journal

    THE USE OF COMBINED PRESERVATION TECHNIQUES FOR EXTENDED STORAGE OF ORTHOTOPIC LIVER HOMOGRAFTS.

    Surgery, gynecology & obstetrics·2010
    Same journal

    The Role of Electrical Pacemakers in the Treatment of Unexpected Cardiac Arrest.

    Surgery, gynecology & obstetrics·2010
    Same journal

    Colonic and proctoscopic diseases.

    Surgery, gynecology & obstetrics·2010
    Same journal

    A summary of the surgical aspects of certain sulfonamides and antibiotic agents.

    Surgery, gynecology & obstetrics·2010
    Same journal

    Penetrating cranial wounds; a summary of methods used in management; collective review.

    Surgery, gynecology & obstetrics·2010
    Same journal

    The use of compression in the treatment of injuries.

    Surgery, gynecology & obstetrics·2010
    See all related articles

    Area of Science:

    • Critical Care Medicine
    • Pharmacology
    • Infectious Diseases

    Background:

    • Septic shock is a life-threatening condition characterized by circulatory dysfunction and organ hypoperfusion.
    • Fever is a common clinical sign in septic shock, often indicating a systemic inflammatory response.
    • The role of corticosteroids in managing septic shock remains an area of clinical interest.

    Purpose of the Study:

    • To evaluate the efficacy of Solu-Medrol (methylprednisolone sodium succinate) in managing fever in patients with septic shock.
    • To assess the impact of Solu-Medrol treatment on the general physical condition of septic shock patients.

    Main Methods:

    • Retrospective analysis of 17 episodes of septic shock.
    • Intravenous administration of a 2-gram bolus of Solu-Medrol.

    Related Experiment Videos

  • Monitoring of patient temperature and general physical condition post-treatment.
  • Main Results:

    • A rapid decrease in temperature was observed within four hours in most patients treated with Solu-Medrol.
    • Accompanying the fever reduction, patients showed improvement in their general physical condition.
    • The hypothermic effect typically lasted approximately 30 hours, with temperature returning to or falling below pre-treatment levels.

    Conclusions:

    • Intravenous Solu-Medrol bolus administration is effective in rapidly reducing fever in septic shock patients.
    • The treatment appears to improve the overall clinical status of patients experiencing septic shock.
    • In non-survivors with overwhelming sepsis, the temperature response was less pronounced and shorter in duration.